NO20042884L - Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater - Google Patents

Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater

Info

Publication number
NO20042884L
NO20042884L NO20042884A NO20042884A NO20042884L NO 20042884 L NO20042884 L NO 20042884L NO 20042884 A NO20042884 A NO 20042884A NO 20042884 A NO20042884 A NO 20042884A NO 20042884 L NO20042884 L NO 20042884L
Authority
NO
Norway
Prior art keywords
trans
preparation
dibenco
cycloheptal
tetrahydro
Prior art date
Application number
NO20042884A
Other languages
English (en)
Norwegian (no)
Inventor
Bart Petrus Anna Maria Medaer
Hua Mao
Yolande Lydia Lang
Tomasz Kozlecki
Frans Josef Cornel Compernolle
Georges Joseph Cornel Hoornaer
Thierry Brossette
Michel Joseph Mauric Giillaume
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20042884L publication Critical patent/NO20042884L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20042884A 2001-12-07 2004-07-07 Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater NO20042884L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204961 2001-12-07
PCT/EP2002/013560 WO2003048146A1 (en) 2001-12-07 2002-12-02 PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES

Publications (1)

Publication Number Publication Date
NO20042884L true NO20042884L (no) 2004-07-07

Family

ID=8181460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042884A NO20042884L (no) 2001-12-07 2004-07-07 Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater

Country Status (20)

Country Link
US (2) US6998494B2 (de)
EP (1) EP1456193B1 (de)
JP (1) JP4516752B2 (de)
KR (1) KR20050044329A (de)
CN (1) CN1293066C (de)
AT (1) ATE294168T1 (de)
AU (1) AU2002342926B2 (de)
BR (1) BR0214068A (de)
CA (1) CA2468038C (de)
DE (1) DE60203937T2 (de)
ES (1) ES2242076T3 (de)
HR (1) HRP20040490A2 (de)
HU (1) HUP0402152A3 (de)
IL (1) IL162349A0 (de)
MX (1) MXPA04005400A (de)
NO (1) NO20042884L (de)
NZ (1) NZ532806A (de)
PL (1) PL369585A1 (de)
WO (1) WO2003048146A1 (de)
ZA (1) ZA200404394B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE294168T1 (de) * 2001-12-07 2005-05-15 Janssen Pharmaceutica Nv Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties
WO2005121113A1 (en) * 2004-06-14 2005-12-22 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives
CA2577305C (en) 2004-08-31 2013-12-17 Janssen Pharmaceutica N.V. Process for the production of [2-(4-fluoro-benzyl)-phenyl]-acetic acid
RU2401257C2 (ru) 2004-12-07 2010-10-10 Янссен Фармацевтика Н.В. Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена
MX2007009092A (es) 2005-01-27 2007-09-12 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos heterociclicos como inhibidores de 5ht2 en el tratamiento de trastornos del sistema nervioso central.
CN101228154B (zh) 2005-06-17 2014-01-29 詹森药业有限公司 包含环状胺侧链的四环四氢呋喃衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69720709T2 (de) * 1996-04-12 2004-03-11 Janssen Pharmaceutica N.V. Substituierte tetracyclische tetrahydrofuranderivate
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
ATE294168T1 (de) * 2001-12-07 2005-05-15 Janssen Pharmaceutica Nv Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten
HUP0402325A2 (hu) * 2001-12-07 2005-02-28 Janssen Pharmaceutica N.V. Eljárás cisz-fuzionált 3,3a,8,12b-tetrahidro-2H-dibenzo [3,4:6,7] ciklohepta [1,2-b]furán-származékok előállítására

Also Published As

Publication number Publication date
US6998494B2 (en) 2006-02-14
HK1076461A1 (en) 2006-01-20
ATE294168T1 (de) 2005-05-15
IL162349A0 (en) 2005-11-20
EP1456193A1 (de) 2004-09-15
US20050014820A1 (en) 2005-01-20
ES2242076T3 (es) 2005-11-01
DE60203937D1 (de) 2005-06-02
JP4516752B2 (ja) 2010-08-04
BR0214068A (pt) 2004-10-13
MXPA04005400A (es) 2004-10-11
CA2468038C (en) 2011-04-26
AU2002342926A1 (en) 2003-06-17
HUP0402152A3 (en) 2007-03-28
WO2003048146A1 (en) 2003-06-12
US20050228043A1 (en) 2005-10-13
CA2468038A1 (en) 2003-06-12
HUP0402152A2 (hu) 2005-02-28
JP2005511691A (ja) 2005-04-28
CN1293066C (zh) 2007-01-03
PL369585A1 (en) 2005-05-02
AU2002342926B2 (en) 2009-02-26
NZ532806A (en) 2006-01-27
ZA200404394B (en) 2005-09-05
DE60203937T2 (de) 2006-05-11
KR20050044329A (ko) 2005-05-12
CN1602306A (zh) 2005-03-30
EP1456193B1 (de) 2005-04-27
HRP20040490A2 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
NZ522568A (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
HUP9701048A2 (hu) Új eljárás sildenafil előállítására és a felhasznált új köztitermékek
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
SE0102616D0 (sv) Novel compounds
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
BR0112693A (pt) (derivados) de ácido sulfonilaminometilbenzóico substituìdos e processo para preparação do mesmo
CA2445306A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
KR860005778A (ko) 나프탈렌 유도체의 제조방법
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
MA29617B1 (fr) Derives de n-(arylalkyl)-1h-pyrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique.
YU94103A (sh) Novi derivati sulfonske kiseline
DE69722004D1 (de) Nukleotidanaloga
DE60203937D1 (de) Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivaten
NO20023405D0 (no) Fremgangsmåte for fremstilling av 5-Cyanoftalid
ID27509A (id) Turunan piridin tersubstitusi-2,3 proses pembuatannya, komposisi farmasi yang mengandung senyawa tersebut, dan senyawa-antaranya
MXPA04005399A (es) Preparacion de derivados cis-fusionados de 3, 3a, 8, 12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b]furano.
WO2001056992A3 (en) Dibenzo (b,f) azepine intermediates
ATE284882T1 (de) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
ATE307103T1 (de) Hyperforin-derivate, ihre verwendung sowie diese enthaltende zubereitungen
WO2004065360A3 (en) Piperazine derivatives and their use as synthesis intermediates
BG106846A (en) Novel heteroaryl derivatives, their preparation and use
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
EE200300058A (et) Imidaso[1,2-c] [2,3] bensodiasepiinide valmistamismeetod ja vaheühendid nende valmistamisel
EP1241167A4 (de) 3-ethyl, 3-propyl- oder 3-butyl-chroman und -thiochromanderivate
DE69811382D1 (de) Carbapenemderivate und herstellungsverfahren dafür

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application